transcriptomics
In a small validation set, the model was able to make accurate predictions about patient outcomes using routinely collected patient data.
Pangea, OHSU Knight Cancer Institute Using AI Platform to Explore Precision Oncology Strategies
The partners will use Pangea's ENLIGHT-DP platform to analyze data from two clinical studies at OHSU and improve understanding of tumor resistance and response.
Caris Life Sciences, ECOG-ACRIN to Analyze Breast Tumor Samples From Landmark TAILORx Study
Through a new partnership, Caris will use its comprehensive genomic profiling tests to sequence more than 10,000 early-stage breast tumors collected in TAILORx.
BostonGene, Mount Sinai Partner on Multiple Myeloma Precision Oncology Study
The study will use BostonGene's assays, including whole-exome and whole-transcriptome sequencing, to inform patients' clinical care and advance drug development.
Pangea Biomed, Hadassah University, Ultima Genomics Team up to Improve Tumor Treatment Predictions
The companies will partner with researchers at Hadassah to apply genomic, transcriptomic, and artificial intelligence technologies to treatment predictions for cancer patients.